Targacept starts new trial for diabetes drug – Bizjournals.com

Targacept starts new trial for diabetes drug
Bizjournals.com
Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase 2 clinical trial, the company has announced.
Targacept to begin phase 2 trials for its anti-inflammatory drug compoundWinston-Salem Journal
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 12 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.